Skip to main content

Singular Genomics Systems, Inc.

OMICDelisted Feb 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0001850906

Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding Singular Genomics Systems, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of OMIC: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders4847−1
Shares27.0M26.2M−806.1K (−3.0%)
Value$10.6M$12.1M+$1.53M (+14.5%)

New holders (5)

Institutions that held Singular Genomics Systems, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to OMIC in Q4 2023
InstitutionSharesValue% of portfolio
XTX Topco Ltd56,261$25.9K0.01%
DLK Investment Management, LLC25,000$11.5K0.01%
Two Sigma Securities, LLC12,558$5.78K0.00%
DAGCO, Inc.1,700$7820.00%
Dynamic Wealth Strategies, LLC1,700$7820.00%

Sold out (6)

Institutions that held Singular Genomics Systems, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of OMIC in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Acuitas Investments, LLC521,876$198.8K
Platinum Investment Management Ltd427,444$162.9K
Jacobs Levy Equity Management, Inc358,676$136.7K
Marquette Asset Management, LLC102,950$39.2K
D. E. Shaw & Co., Inc.51,441$19.6K
Jane Street Group, LLC12,977$4.94K